Related Experiment Video
Updated: May 5, 2026

Imaging Approaches to Assessments of Toxicological Oxidative Stress Using Genetically-encoded Fluorogenic Sensors
Published on: February 7, 2018
Oxidative and nitrosative stress in the metastatic microenvironment
Angel L Ortega1, Salvador Mena, José M Estrela
1Department of Physiology, Faculty of Medicine and Odontology, University of Valencia, 15 Av. Blasco Ibañez, 46010 Valencia, Spain. jose.m.estrela@uv.es.
Metastatic cancer cells adapt and survive conventional therapies through complex molecular events. Reactive oxygen and nitrogen species (ROS and RNS) play crucial roles in this adaptation, leading to treatment resistance.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Metastases resistant to conventional therapies cause most cancer deaths.
- Tumor cell heterogeneity and microenvironmental factors complicate cancer therapy.
- Metastasis involves critical interactions between cancer cells and the vascular endothelium.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying metastatic cell survival and therapy resistance.
- To identify key molecular targets essential for the survival of invasive metastatic cell subsets.
- To understand the role of reactive oxygen and nitrogen species (ROS and RNS) in metastasis.
Main Methods:
- Analysis of molecular events during cancer cell interaction with endothelium.
- Investigation of cellular responses to microenvironmental factors and immune attack.
- Examination of the role of ROS and RNS in metastatic cell adaptation and survival.
Main Results:
- Cancer cell-endothelial cell interactions trigger activation pathways involving cytokines, growth factors, lipids, ROS, and RNS.
- Endothelium-derived NO and H2O2 exhibit cytotoxicity but also reveal critical survival targets for metastatic cells.
- Metastatic cells undergo dynamic adaptations, influenced by immune cells and organ-specific microenvironments, leading to resistant phenotypes.
Conclusions:
- Metastatic progression and therapy resistance are driven by dynamic cellular adaptations.
- ROS and RNS are pivotal in facilitating the survival of highly resistant malignant cell subsets.
- Targeting molecular pathways involving ROS and RNS may offer new therapeutic strategies against resistant metastases.
Related Concept Videos
Bioactivation and Tissue Toxicity
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
The Tumor Microenvironment
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Oxygen Requirements and Growth Patterns

